While the molecular findings with a JAK2 R564L point mutation suggested an overlap MDS/MPN syndrome, the presence of markedly increased ring sideroblasts in the absence of thrombocytosis argued against the diagnosis of an MDS/MPN-RS-T. Here, JAK2 is linked to myeloproliferative disorder.